Global Bioanalytical Testing Services Market - 2023-2030

Overview

Bioanalytical testing services play an important role in drug discovery and development and in quantifying drugs and their metabolites or related biomarkers in biological fluids. Bioanalytical methods are used to evaluate pharmacokinetics and toxic kinetic studies and these methods can be applied to study human clinical pharmacology and toxicology.

Bioanalytical testing involves the process of identifying and quantifying drugs within various biological matrices, such as blood, plasma, serum, cerebrospinal fluid, saliva, and urine. Common bioanalytical testing types include pharmacokinetic testing, pharmacodynamics testing, and ADME testing.

Market Dynamics

Increasing expenditure on bioanalytical services

Bioanalytical testing involves using a validated bioanalytical method for the quantitative evaluation of analytes in the given biological matrix. The increasing expenditures for bioanalytical testing services act as a significant driver for market growth. Also, many key players play a major role in the advancements of the market by opening new bioanalytical testing services.

For instance, in September 2022, Eurofins Scientific declared an agreement to invest its Digital Testing business to Stirling Square Capital Partners for €220m on a cash and debt-free basis. It supports the Group's capital allocation priorities, including capital expenditure in laboratories, digitalization, and acquisitions to further enhance its leadership in bioanalytical testing and other life science areas.

Also, in November 2021, BioAgilytix declared an agreement to be further capitalized by Cinven. The investment by Cinven provides BioAgilytix with increased funding and resources to meet the growing demand for its high-quality bioanalytical services, driven by its strong scientific reputation and leading expertise in supporting the development and commercialization of novel therapeutics.

Additionally, in April 2021, Vitruvian Partners reported the strategic growth investment in KCAS Bioanalytical and Biomarker Services. The company provides expertise in biological (big molecule) and synthetic (small molecule) therapeutic prospects and provides a full spectrum of bioanalytical services from early discovery support through registration.

Furthermore, significant growth drivers such as the growing demand for bioanalytical services, research and developments, and service acquisitions are expected to drive the market in the forecast period.

Challenges in bioanalytical development method

Various challenges in bioanalytical development can hamper market growth. Developing and validating bioanalytical methods is a complex process that demands an agile approach. Researchers encounter numerous challenges in this regard, including calculation errors, flawed extraction techniques, and analytical issues, as outlined by FDA reviewers.

Segment Analysis

The global bioanalytical testing services market is segmented based on test type, molecule type, end users, and region.

The small molecule segment accounted for approximately 37.2% of the market share

Small molecule bioanalysis is the chemical analysis of compounds within a biological matrix. Small molecules are traditional pharmaceuticals and have a low molecular weight of less than 900 Daltons and regulate a biological process. Small molecule testing is expected to hold the largest market share over the period forecast owing to increasing developments and advancements of small molecule testing services.

For instance, in August 2023, Metrion Biosciences Limited decided to offer GLP-compliant hERG ion channel screening services to the global life sciences community. GLP hERG screening is a crucial part of the process when transitioning from preclinical research to Phase 1 clinical trials in humans. Additionally, it's an important step in the Investigational New Drug (IND) application process for potential small molecule therapeutics.

Additionally in August 2022, BioDuro Sundia launched the DNA Encoded Compound Library (DEL) technology services in China to help more innovative pharmaceutical companies quickly discover small molecule drugs.

Geographical Analysis

North America is expected to hold a significant position in the global bioanalytical testing services market share

The global bioanalytical testing services market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa. North America has maintained a significant market proportion due to factors such as the rising demand for bioanalytical services, and service acquisitions, and this trend is anticipated to continue throughout the forecast period.

For instance, in July 2022, U.S. Alliance Pharma acquired U.K.-based LGC's Drug Development Solutions (DDS) Business. This acquisition broadens the bioanalytical, analytical material testing, and laboratory capabilities for the biopharma and pharma businesses internationally.

In October 2022, Thermo Fisher Scientific extended its clinical research operations with the development of a cutting-edge bioanalytical lab in Richmond, Virginia in the United States. The new facility helps meet the rising demand for dependable, top-notch laboratory services needed to accelerate the development of new drugs in the biopharmaceutical industry.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the bioanalytical testing services market. The bioanalytical laboratory has modified its routine lab procedures and clinical trial procedures due to travel and personnel constraints. The reduction in the availability of lab supplies, reagents, personal protective equipment (PPE), and biological matrices is the outcome of logistical supply chain issues. Therefore, the bioanalytical testing services market is expected to be moderately affected over the forecast period.

Market Segmentation

By Test Type

• Pharmacokinetic (PK) Testing
• Pharmacodynamics (PD) Testing
• ADME Testing
  • In-Vivo ADME
  • In-Vitro ADME

• Bioavailability Testing
• Bioequivalence Testing
• Others

By Molecule Type

• Small Molecule
• Large Molecule
  • Immunoassays
  • LC-MS Studies
  • Others

By End Users

• Biopharmaceutical Companies
• Clinical Research Organizations
• Contract Development and Manufacturing Organization (CDMO)
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico

• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe

• South America
  • Brazil
  • Argentina
  • Rest of South America

• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific

• Middle East and Africa

Competitive Landscape

The major global players in the market include: Syneous Health, SGS S.A, ICON Plc, Charles River Laboratories Inc., Laboratory Corporation of America Holdings, Intertek Group Plc., Q2 Solutions, Pace Analytical Services LLC, Prolytix, Frontage Laboratories among others.

Key Developments

• In September 2023, Cerba HealthCare acquired CIRION Biopharma Research Inc (CIRION). The goal is to enhance our bioanalytical capabilities and reduce the time required to launch intricate clinical trials.
• In December 2022, Alliance Pharma opened its new 20,000-square-foot bioanalytical laboratory, Alliance Pharma Pty, Ltd., in Brisbane, Australia.
• In Jan 2021, Nexelis acquired the GSK vaccines clinical bioanalytical laboratory located in Marburg Germany, and entered into a 5-year strategic agreement with GSK.

Why Purchase the Report?

• To visualize the global bioanalytical testing services market segmentation based on test type, molecule type, end users, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of global bioanalytical testing services market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global bioanalytical testing services market report would provide approximately 61 tables, 60 figures, and 185 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies